Chronic inflammation seems implicated in the pathophysiology of chronic kidney diseases (CKD) and the development of its complications, such as cardiovascular diseases (CVD). Genes encoding inflammatory molecules are, hence, good candidates for CVD risk in haemodialysis patients (HD). We therefore evaluated whether +896A1G TLR4 polymorphism and CCR5~32 deletion are risk factors for CKD and CVD. We examined the two gene variants in 72 HD patients and in 125 controls from Sicily. No significant differences in the genotype distribution and allele frequencies of the two gene variants were observed between patients and controls. The same results were obtained by analysing the combined effect of the two proinflammatory (+896ATLR4 and wt CCR5) alleles. However, the high responder proinflammatory (+896A+TLR4/wHCCR5) genotype seems to be a possible independent risk factor for CVD development in HO patients. Our results suggest that HO patients with a high responder proinflammatory genotype have an increase CVO risk.
Chronic kidney disease (CKD) represents a worldwide public health problem in the 21sl century. Its pathogenesis and seriousness are complex and variable. Cardiovascular diseases (CVD) are the leading causes of complications and death in patients with chronic haemodialysis (HD) (I). Inflammation and innate immunity play a relevant role in the CKD onset and progression, and its complications (2) . Innate immunity represents a driving force in the progression of many renal diseases (3) . In particular, the involvement of Toll-like receptors (TLRs) in the pathogenesis of infection-mediated and autoimmunity-mediated CKD has also been demonstrated (4). Among TLR members, the receptor for lipopolysaccharide, TLR4, plays a critical role in the susceptibility of HD patients to CVD (5) . Moreover, the CCR5 (CC-chemokine receptor-5), a p-chemokines receptor, also seems to be involved in the onset and progression of CVD (6) . The activity of these molecules seems to be modulated by genetic variants, principally single nucleotide polymorphisms. A common and functional SNP of TLR4 gene (NM-138554), the +896A/G polymorphism (rs4986790), has been recently identified (7) . The +896A/G SNP induces a blunted innate/inflammatory response to both foreign The data were testedfor the goodness offit between the observed and expected genotype frequencies according to Hardy-Weinberg equilibrium (HWE) by X2 test. and all the genotypes were in HWE. By X2 test. the +896A/G TLR4 genotype distribution was not significantly distributed between the 2 cohorts. Accordingly. the allele frequency of +896A/G TLR4 SNP was not significantly distributed among the 2 cohorts. By X2 test, the CCR5!J.32 genotype distribution and the allele frequency were not significantly different between the two cohorts. Moreover, analysing by X2 tests the combined effect of two pro inflammatory (+896A TLR4 and wt CCR5) alleles. no significant differences were found between the two cohorts.
pathogens and endogenously generated inflammatory ligands (7) (8) . Furthermore, a non-functional allele of CCR5 gene (NM-U83326), resulting from a 32-bp deletion in exon 4 (CCR5L\32 deletion; rs333) is well known (9) . It determines a loss of expression of functional CCR5 receptor and, as a consequence, an attenuated inflammatory response (9) . Genetic data have demonstrated the association of +896A/ G TLR4 polymorphism and CCR5!J.32 deletion with CVD (l0). Recently, the association between allelic variants in genes related to innate immunity and CKD has been also highlighted (8) . Taking into consideration these observations, the aim of the present study is to evaluate whether +896A/G TLR4 polymorphism and CCR5!J.32 deletion arc risk factors for CKD and its CVD complications.
We enrolled 72 subjects admitted to the Dialysis Unit of Palermo University Hospital. The patients had all been on HD for at least 8 months (median 70) and were all treated by standard bicarbonate dialysis for 4 h 3 times per week using Polyflux (Gambro Dialysatoren GmbH, Hechingen, Germany) or Arylane Serie L synthetic membranes (Gambro Industries, Meyzieu Cedex, France), maintaining a urea reduction ratio 2: 75%. Information on concomitant hypertension, diabetes mellitus, dyslipidemia and smoking was obtained from hospital charts; patients were asked to provide information on their smoking habits. CVD was defined as the presence or history of ischemic heart disease, peripheral vascular disease, pulmonary thromboembolism and cerebrovascular event. The prevalence was: hypertension 48%, diabetes 23%, dyslipidaemia 28% and smoking 27%. Moreover, among the HD patients 37 (50%) were affected by severe CVD (22 patients affected by coronary heart diseases, 5 by cerebrovascular diseases and 10 atherosclerotic vascular diseases). They exhibited higher prevalence of CVD risk factors than the other patients (obesity 33%; hypertension 65%; hypercholesterolemia 62% and hypertriglyceridemia 41%; family history of CVD 49%; type 2 diabetes 18%; smoking 36%). The matched control group consisted of 125 subjects in good health, based on their clinical history and on blood tests. Among young controls 21.3% were moderate smokers; no other cardiac risk factor was present. The study was approved by the University Hospital Ethics Committee and written informed consent was obtained from all participants.
DNA was extracted by standard salting-out method and it was genotyped for +896A/G TLR4 polymorphism and CCR5~32 deletion as previously published (12-I3). Differences in allele and genotype frequencies of the two genetic variants among the two groups were evaluated by gene count and by X2 test. A multiple regression analysis was performed to test whether the high responder pro-inflammatory (+896A+TLR4/wHCCR5) genotype is a possible independent risk factor for developing CVD complication in HD Sicilian patients, taking into account smoking habits, family history of CVD and the presence of type 2 diabetes, obesity, hypertension, hypercholesterolemia and hypertriglyceridemia.
No significant differences were observed in genotype distribution and allele frequencies of two polymorphisms studied between the patients and controls (Table 1 ). In addition, analysing by X2 tests the combined effect of the two proinflammatory (+896ATLR4 and wt CCR5) alleles, no significant differences were found between the two cohorts (data not shown). However, the multiple regression analysis evidenced, considering the risk factors above described, that the +896A+TLR41 wHCCR5genotype is a significant risk factor for the development of COV complications in Sicilian HD patients (p=0.041; Odds Ratio 4.1 (1.8-4.6».
The results of the present study seem to indicate that pro-inflammatory alleles of the genes under study influence the progression and the seriousness of CKD, such as the onset of its CVO complication, in the Sicilian population. In particular, our results appear to show that HD patients with a higher responder pro-inflammatory genotype seem to have an increase risk for CVD.
On the whole, our data seems to suggest a major role ofthe intensity ofgenetically determined inflammatory responses against pathogens or endogenous molecules in the developing and progression of inflammatory diseases such as CDK and subsequent clinical outcomes. Accordingly, in a recent review of Candore et aI., we suggested that the detection of a risk profile will potentially allow both the early identification of individuals susceptible to the disease and the possible discovery of potential selective drug therapy and lifestyle modification (10) .
